Abstract
In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions
(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legal
scholars;, and regulation specialists to consider key issues raised by the Act.
(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legal
scholars;, and regulation specialists to consider key issues raised by the Act.
| Original language | English |
|---|---|
| Pages (from-to) | 157-161 |
| Number of pages | 5 |
| Journal | Medical Law Review |
| Volume | 22 |
| Issue number | Special Issue: 2 |
| DOIs | |
| Publication status | Published - 1 Jun 2014 |
| Externally published | Yes |